{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:47:34Z","timestamp":1762112854746,"version":"build-2065373602"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>There is a growing population of solid organ transplant (SOT) survivors who subsequently require a hematopoietic cell transplant (HCT), although there are limited data on survival, risk factors for SOT graft loss, and death in this cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>This retrospective Center for International Blood and Marrow Transplant Research study included recipients of SOT followed by HCT between 1989 and 2017. HCT data were merged with organ transplant data from the Organ Procurement and Transplantation Network.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Eighty-three patients with an SOT underwent an HCT. Organs transplanted included heart\/lung (thoracic, n\u2005=\u200515), kidney (n\u2005=\u200542), and liver (n\u2005=\u200526); 24 patients (29%) received a living donor graft and 59 (71%) a deceased graft. Forty-one patients (49.4%) received an allogeneic HCT and 42 (50.6%) an autologous HCT. Three-year overall survival (OS) from HCT in the entire cohort was 38.6%. There were no significant differences in OS by SOT type, although 3-y OS appeared lowest in the kidney SOT group at 29.9%, compared with liver SOT at 40.6% and thoracic SOT at 58.2%. The incidence of SOT graft failure 3 y post-HCT was 59.1%. There were no significant differences in SOT graft failure by organ type: 3-y failure probability 67.2% for kidney, 56.5% for liver, and 46.2% for thoracic. Shared risk factors for death and graft failure included HCT indication (leukemia, lymphoma, and nonmalignant diseases), HCT type (allogeneic), and SOT type (kidney).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Although some SOT recipients may benefit from HCT, the incidence of SOT graft failure was high and OS was poor, particularly after allogeneic HCT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000005377","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:01:05Z","timestamp":1750636865000},"page":"1611-1625","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study"],"prefix":"10.1097","volume":"109","author":[{"given":"Meera","family":"Gupta","sequence":"first","affiliation":[{"name":"Division of Transplantation, Department of Surgery, University of Kentucky, College of Medicine, Lexington, KY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle L.","family":"Schoettler","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta, Aflac Blood and Cancer Disorder Center, Emory University, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Orozco","sequence":"additional","affiliation":[{"name":"Oregon Health and Science University, Portland, OR."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Brazauskas","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI."},{"name":"CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Bo-Subait","sequence":"additional","affiliation":[{"name":"CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoo","family":"Battiwalla","sequence":"additional","affiliation":[{"name":"Sarah Cannon Transplant and Cell Therapy Network, Nashville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Buchbinder","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Children\u2019s Hospital of Orange County, Orange, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty K.","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bipin N.","family":"Savani","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Schoemans","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Hospitals Leuven, Leuven, Belgium."},{"name":"Department of Public Health and Primary Care, ACCENT VV, KU Leuven\u2013University of Leuven, Leuven, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed L.","family":"Sorror","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Department of Medicine, Fred Hutchinson Cancer Center, University of Washington School of Medicine, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma and Stem Cell Transplantation, University of Texas, MD Anderson Cancer Center, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif M.","family":"Badawy","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL."},{"name":"Division of Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Bhushan","sequence":"additional","affiliation":[{"name":"Medical City Dallas Hospital, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Birdsey","sequence":"additional","affiliation":[{"name":"The Colorado Blood Cancer Institute, a part of Sarah Cannon Cancer Institute at Presbyterian\/St Luke\u2019s Medical Center, Denver CO; HCA Healthcare, Nashville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Couriel","sequence":"additional","affiliation":[{"name":"Transplant and Cellular Therapy Program, Huntsman Cancer Center Institute, University of Utah, Salt Lake City, Utah."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E.","family":"Doherty","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine\/Texas Children\u2019s Hospital, Houston TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Donato","sequence":"additional","affiliation":[{"name":"Hackensack University Medical Center, Hackensack, NJ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif S.","family":"Farag","sequence":"additional","affiliation":[{"name":"Stem Cell Transplant and Cellular Therapy Institute, Community Health Network MD Anderson Center, Indianapolis, IN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Gutman","sequence":"additional","affiliation":[{"name":"Division of Hematology, University of Colorado, Aurora, CO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Horwitz","sequence":"additional","affiliation":[{"name":"Duke University Medical Center, Durham, NC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najla","family":"El Jurdi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph E.","family":"Maakaron","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Maziarz","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health and Science University, Portland, OR."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Pineiro","sequence":"additional","affiliation":[{"name":"Baylor University Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Schiller","sequence":"additional","affiliation":[{"name":"Hematological Malignancy\/Stem Cell Transplant Program, David Geffen School of Medicine at UCLA, Los Angeles, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Weisdorf","sequence":"additional","affiliation":[{"name":"Division of Hematology, University of Colorado, Aurora, CO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basem M.","family":"William","sequence":"additional","affiliation":[{"name":"Ohio Health Blood and Marrow Transplant and Cell Therapy Program, Columbus, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwen E.","family":"Shaw","sequence":"additional","affiliation":[{"name":"CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Phelan","sequence":"additional","affiliation":[{"name":"CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI."},{"name":"Division of Pediatric Hematology\/Oncology\/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Porter","sequence":"additional","affiliation":[{"name":"Center for Cell Therapy and Transplant, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Levine","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine University of Pennsylvania and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter L.","family":"Abt","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"R1-20250924","article-title":"Citing data."},{"key":"R2-20250924","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/lt.25320","article-title":"Liver transplantation today: where we are now and where we are going.","volume":"24","author":"Bodzin","year":"2018","journal-title":"Liver Transpl"},{"key":"R3-20250924","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16502","article-title":"OPTN\/SRTR 2019 annual data report: kidney.","volume":"21","author":"Hart","year":"2021","journal-title":"Am J Transplant"},{"key":"R4-20250924","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/ajt.16495","article-title":"OPTN\/SRTR 2019 annual data report: lung.","volume":"21","author":"Valapour","year":"2021","journal-title":"Am J Transplant"},{"key":"R5-20250924","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrclinonc.2015.186","article-title":"Post-transplantation malignancies: here today, gone tomorrow?","volume":"12","author":"Geissler","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"R6-20250924","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2165\/00003495-200767080-00006","article-title":"Immunosuppressive therapy and malignancy in organ transplant recipients.","volume":"67","author":"Gutierrez-Dalmau","year":"2007","journal-title":"Drugs"},{"key":"R7-20250924","doi-asserted-by":"crossref","first-page":"17202","DOI":"10.1038\/s41598-019-53163-9","article-title":"De novo cancer incidence after kidney and liver transplantation: results from a nationwide population based data.","volume":"9","author":"Park","year":"2019","journal-title":"Sci Rep"},{"key":"R8-20250924","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/cncr.28043","article-title":"Cumulative incidence of cancer after solid organ transplantation.","volume":"119","author":"Hall","year":"2013","journal-title":"Cancer"},{"key":"R9-20250924","first-page":"233","article-title":"Neoplastic complications of transplantation.","volume":"8","author":"Penn","year":"1993","journal-title":"Semin Respir Infect"},{"key":"R10-20250924","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet"},{"key":"R11-20250924","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbmt.2020.03.002","article-title":"Indications for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the American Society for Transplantation and Cellular Therapy.","volume":"26","author":"Kanate","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"R12-20250924","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","article-title":"Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022.","volume":"57","author":"Snowden","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"R13-20250924","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/bloodadvances.2021004394C","article-title":"American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation.","volume":"5","author":"Kanter","year":"2021","journal-title":"Blood Adv"},{"key":"R14-20250924","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives.","volume":"7","author":"Castagnoli","year":"2019","journal-title":"Front Pediatr"},{"key":"R15-20250924","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/1097-0142(19911115)68:10<2095::AID-CNCR2820681002>3.0.CO;2-Y","article-title":"Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation.","volume":"68","author":"Yokoyama","year":"1991","journal-title":"Cancer"},{"key":"R16-20250924","doi-asserted-by":"crossref","first-page":"87.e1","DOI":"10.1016\/j.bbmt.2020.09.005","article-title":"Hematopoietic cell and solid organ transplantation in the same patient: long-term experience at the University of Minnesota.","volume":"27","author":"El Jurdi","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"R17-20250924","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/bmt.2011.153","article-title":"Hematopoietic stem-cell transplantation following solid-organ transplantation in children.","volume":"46","author":"Schechter-Finkelstein","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"R18-20250924","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"R19-20250924","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the disease risk index for allogeneic stem cell transplantation.","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"R20-20250924","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading.","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R22-20250924","doi-asserted-by":"crossref","first-page":"a015677","DOI":"10.1101\/cshperspect.a015677","article-title":"Cancer in the transplant recipient.","volume":"3","author":"Chapman","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R23-20250924","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients.","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"R24-20250924","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/ajt.13017","article-title":"Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter Study of the EBMT.","volume":"15","author":"Basak","year":"2015","journal-title":"Am J Transplant"},{"key":"R25-20250924","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.bbmt.2015.08.004","article-title":"Hematopoietic cell transplantation after solid organ transplantation.","volume":"21","author":"Doney","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R26-20250924","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbmt.2019.08.021","article-title":"Hematopoietic stem cell transplantation in solid organ recipients with emphasis on transplant complications: a nationwide retrospective survey on behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Group.","volume":"26","author":"Shinohara","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"R27-20250924","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/TP.0b013e3181a238f6","article-title":"De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.","volume":"87","author":"Miao","year":"2009","journal-title":"Transplantation"},{"key":"R28-20250924","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/leu.2014.132","article-title":"Risk of myeloid neoplasms after solid organ transplantation.","volume":"28","author":"Morton","year":"2014","journal-title":"Leukemia"},{"key":"R30-20250924","doi-asserted-by":"crossref","first-page":"e0269990","DOI":"10.1371\/journal.pone.0269990","article-title":"Risk factors for graft loss and death among kidney transplant recipients: a competing risk analysis.","volume":"17","author":"Pinto-Ramirez","year":"2022","journal-title":"PLoS One"},{"key":"R31-20250924","doi-asserted-by":"crossref","first-page":"e1273","DOI":"10.1097\/TXD.0000000000001273","article-title":"Death with function and graft failure after kidney transplantation: risk factors at baseline suggest new approaches to management.","volume":"8","author":"Merzkani","year":"2022","journal-title":"Transplant Direct"},{"key":"R32-20250924","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ejhf.886","article-title":"Late graft failure in heart transplant recipients: incidence, risk factors and clinical outcomes.","volume":"20","author":"L\u00f3pez-Sainz","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"R33-20250924","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/crj.13471","article-title":"Graft dysfunction and rejection of lung transplant, a review on diagnosis and management.","volume":"16","author":"Sun","year":"2022","journal-title":"Clin Respir J"},{"key":"R34-20250924","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.3748\/wjg.v27.i45.7771","article-title":"Chronic rejection after liver transplantation: opening the Pandora\u2019s box.","volume":"27","author":"Angelico","year":"2021","journal-title":"World J Gastroenterol"},{"key":"R35-20250924","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood-2015-12-685107","article-title":"Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants.","volume":"127","author":"Strober","year":"2016","journal-title":"Blood"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T20:00:48Z","timestamp":1758744048000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005377","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"type":"print","value":"0041-1337"},{"type":"electronic","value":"1534-6080"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}